The Neuroscience:Translate grant program supports research projects at the intersection of biology, engineering and medicine to address practical unmet needs in brain health and the neurosciences.
The program funds cross-disciplinary teams to develop new devices, diagnostic procedures, software, pharmaceutical therapies and other products that can be brought rapidly to market through new startup companies or partnerships with existing entities.
This program was inspired by the successful Stanford Coulter Translational Research program, a partnership between Stanford Bioengineering and the Coulter Foundation managed by the Stanford Mussallem Center for Biodesign. The Wu Tsai Neurosciences Institute has partnered with Stanford Biodesign to bring this same approach and expertise to bear on the field of neuroscience and brain diseases, with guidance from a Neuroscience:Translate oversight committee comprising scientific and industry leaders in health technology development.
The Neuroscience:Translate Grant Program is currently on pause and is not accepting new applications at this time. This pause does not affect existing awards or current grantees. We appreciate the continued interest in the program and will post updates regarding future funding opportunities as they become available.
For questions, please contact neuroscience@stanford.edu.
Apply for the 2026 Neuroscience:Translate Awards
Applications for the 2026 Awards are open from September 22, 2025 to October 20, 2025.
